Published in

Public Library of Science, PLoS Biology, 3(14), p. e1002372, 2016

DOI: 10.1371/journal.pbio.1002372

Links

Tools

Export citation

Search in Google Scholar

Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Journal article published in 2016 by Glenda E. Gray, Fatima Laher, Tanya Doherty, Salim Abdool Karim ORCID, Salim Abdool Karim, Scott Hammer, John Mascola, Chris Beyrer, Larry Corey
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date—a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.